Special GLP-1 Question, Part 1
Scott is a 57-year-old white male who has been diagnosed with type 2 diabetes mellitus (T2DM) for 4 years. Upon diagnosis, with a glycosylated hemoglobin (A1c) level of 7.3%, he was initiated on lifestyle modifications plus...
Letter from the Editor #611: DEWL Results and "Low-Carb"
This week there is a wealth of information on new drugs for diabetes and weight loss; see FDA Approves Eli Lilly Diabetes Combo Drug...
Nike Fuel Band: Tracks All Physical Activities
Nike Fuel Band: Tracks All Physical Activities
Nike...
"Spam" in a Can Tied to Diabetes Risk
Native Americans who often ate processed meat in a can (generically known as "spam," a common food on reservations, and subsidized by the U.S. government) had a two-fold increased risk of developing diabetes over those who ate little or none,...
Dietary Fiber as a Treatment for Type 2 Diabetes
Evidence of the relationship between fiber intake and control of diabetes is mixed. The purpose of the study was to determine if an increase in dietary fiber affects glycosylated hemoglobin (HbA1c) and fasting blood glucose in patients with type 2...
Most Consumers Don't Understand Nutritional Labels
A survey of more than 25,000 consumers in 56 countries, found that about 6 out of 10 consumers (59%) have difficulty comprehending nutritional labels and just 52% understood them "in part." Consumers in North America showed the most confidence in...
Gene Study Sheds Light on Body Clock's Link to Diabetes
A mutation affecting a sleep-wake hormone may disrupt blood sugar control....
Effect of Sitagliptin on Serum Total Ghrelin Levels in Type 2's
In this study of patients with type 2 diabetes, treatment with sitagliptin was associated with a significant decrease in serum ghrelin levels....
FDA Approves Eli Lilly Diabetes Combo Drug Jentadueto
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company announced the FDA approved Jentadueto™ (linagliptin/metformin hydrochloride) tablets....
Metformin May Help Protect Women against Pancreatic Cancer
A new study links the diabetes drug metformin to fewer cases of pancreatic cancer -- at least in women -- but finds other diabetes medications are associated with a higher risk of the disease....
Risks of Tight BP Control May Outweigh Benefits
In diabetes patients, the stroke-preventing benefits of bringing systolic blood pressure below 130 mmHg may be offset by an increased risk of cardiac events....
Electronic Health Records Improve Care for Type 2 Diabetes Patients
Use of electronic health records shows promise for improving care and outcomes in patients with type 2 diabetes, but still has considerable room for improvement....
Pollution Tied to Diabetes and Hypertension Risk
In a study of more than 4,000 black women in Los Angeles, those who lived in areas with higher levels of traffic-related air pollution were at increased risk of diabetes and hypertension....
Efficacy and Safety of Bydureon Versus Metformin, Pioglitazone, and Sitagliptin as Monotherapy
In a once weekly injection of exenatide for Drug-Naive Patients with Type 2 Diabetes (DURATION-4) in a 26-week double-blind study they found that exenatide once weekly (EQW) was noninferior to metformin (MET) but not pioglitazone (PIO) and...
Obesity Drug to Get Broader Label
Vivus Inc said the FDA has asked the company to remove a contraindication in the proposed label of its obesity drug Qnexa, a move that could help it reach a broader patient population....
Obesity Diagnosis May Depend on Medical Professionals Weight
The study findings indicate that medical professionals with normal BMI more frequently reported discussing weight loss with patients than overweight or obese medical professionals....
New Predictors May Determine Metabolic Risk in Kids on Atypicals
Two new studies from a team of investigators suggest two possible predictors for the development of metabolic syndrome in children prescribed second-generation antipsychotics (SGAs)....
A Cost Comparison of a Basal-Bolus Regimen Vs. Premixed Insulin in Type 2's
The study investigated the comparative costs of two different insulin regimens in type 2 diabetes based on data from the GINGER study, which investigated the efficacy and safety of an intensified insulin regimen....
